A Prospective Observational Study: Are There Any Relationships Between Erythrocytosis, Renal Tubular–Glomerular Functions, and Systemic Hypertension in Adolescent Male Idiopathic Erythrocytosis Patients? [PDF]
Background: Childhood hypertension is an important predictor of adult cardiovascular disease. Idiopathic erythrocytosis in adolescent males is characterized by elevated hemoglobin and hematocrit levels, which may increase blood viscosity and potentially ...
Nesrin Tas +3 more
doaj +2 more sources
Erythrocytosis associated with IgA nephropathy
Summary: Background: Erythrocytosis is a hematological disorder usually related to hematopoietic stem cell somatic mutations. However, unexplained erythrocytosis remains frequent.
Kanit Bhukhai +2 more
exaly +3 more sources
Vaping‐Induced Erythrocytosis Resolved With Cessation of e‐Cigarette Use [PDF]
Vaping use is a global health concern with multiple adverse general health effects. We report a young man with vaping‐induced erythrocytosis that resolved following cessation of e‐cigarette use.
Jenyvette Hsia +4 more
doaj +2 more sources
Prevalence and thrombotic risk of SGLT-2 inhibitor-associated erythrocytosis: a retrospective cohort study [PDF]
Background Sodium-glucose cotransporter 2 (SGLT-2) inhibitors, widely used for type 2 diabetes and cardiorenal conditions, may induce erythrocytosis, potentially increasing cardiovascular risk.
Ji Yun Lee +16 more
doaj +2 more sources
Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study [PDF]
Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) increase haemoglobin and haematocrit levels, potentially causing secondary erythrocytosis—defined as a haemoglobin level above 16.5 g/dL in men and 16.0 g/dL in women—which is associated with ...
Abdullahi Ahmed Mohamed +15 more
doaj +2 more sources
Erythrocytosis and thromboembolic risks associated with SGLT2 inhibitors in type 2 diabetes [PDF]
This study aimed to determine if sodium-glucose co-transporter-2 inhibitors (SGLT2i) use in diabetic patients leads to erythrocytosis and increases the incidence of arterial and venous thrombosis events. This is a retrospective cohort study using records
Yu-Han Chen +8 more
doaj +2 more sources
An erythrocytosis is present when the red blood cell mass is increased, demonstrated as elevated hemoglobin and hematocrit in the laboratory evaluation.
Aleša Kristan +19 more
doaj +1 more source
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis
Erythrocytosis is a clinical condition characterized by increased red cell mass, hemoglobin, and hematocrit values. A significant fraction of patients is described as having idiopathic erythrocytosis.
Antonella Zagaria +15 more
doaj +1 more source
Background Multidrug-resistant tuberculosis (MDR-TB) drugs have never been associated with erythrocytosis. In Eritrea, however, several cases of incident erythrocytosis had been observed in the MDR-TB hospital.
Henok Woldu +5 more
doaj +1 more source
High oxygen affinity hemoglobin (HOAH) variants are rare hemoglobinopathies sometimes associated with congenital erythrocytosis. Patients with HOAH are usually asymptomatic and are incidentally discovered when unexplained erythrocytosis is observed in ...
Husain Alkhaldy +5 more
doaj +1 more source

